Protein Assays Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

The Global Protein Assays Market is anticipated to expand from USD 3.11 billion in 2025 to USD 4.73 billion by 2031, reflecting a compound annual growth rate (CAGR) of 7.24%. These crucial biochemical techniques are widely used to detect, quantify, and characterize proteins in biological samples across basic research, diagnostic testing, and drug development. Market growth is primarily fueled by an intensified emphasis on proteomics, a growing pipeline of biologics and biosimilars, and the broader shift toward personalized medicine. Supporting this trajectory, the World Intellectual Property Organization’s 2024 Global Innovation Index noted that global corporate research and development spending hit about $1.2 trillion in 2023, accompanied by a 10% year-over-year increase in pharmaceutical R&D investments.

Even with these strong growth catalysts, the market faces notable hurdles that could slow its advancement. The need for significant upfront financial investments in sophisticated equipment, coupled with the necessity for highly trained personnel to execute complex procedures and analyze difficult data, remains a prominent barrier to widespread expansion.

Market Driver

Rising research and development investments in the pharmaceutical and biotechnology sectors are major catalysts for the Global Protein Assays Market, accelerating the discovery and validation of novel drug targets. These assays serve as vital instruments across all phases of drug development - from initial discovery to clinical testing - enabling the assessment of protein interactions, biomarker identification, and therapeutic efficacy. For example, Johnson & Johnson’s Q4 2025 Earnings Report (January 2026) highlighted a full-year R&D spend of $14.7 billion, reflecting a deep commitment to innovation that fuels the need for advanced protein analysis tools. Such sustained financial backing guarantees a steady flow of prospective therapies that all depend on comprehensive protein evaluation.

The continued growth of the biopharmaceutical sector acts as another primary market driver, as it heavily relies on accurate protein measurement for product creation, quality assurance, and strict regulatory adherence. Manufacturing protein-based treatments like biologics and biosimilars requires constant oversight to guarantee safety, strength, and purity at every production phase. As reported by the Association of the British Pharmaceutical Industry on May 20, 2025, BioNTech pledged up to £1 billion over a decade to grow its UK footprint, illustrating scaling initiatives that naturally boost protein assay usage. Additionally, a July 2025 Biotechnology Innovation Organization report showed biotech startups secured $2.6 billion during the first quarter of the year, emphasizing the escalating financial support for protein analysis technologies throughout the life sciences field.

Market Challenge

The steep capital requirements for state-of-the-art equipment present a direct obstacle to the expansion of the Global Protein Assays Market. Purchasing advanced platforms, including automated liquid handlers and mass spectrometers, involves hefty initial expenses that form major financial roadblocks for smaller research facilities and newer biotech firms. This economic pressure restricts the integration of next-generation tools necessary for thorough protein evaluation. Highlighting this cautious spending environment, a 2023 survey by Lab Manager revealed that a mere 35 percent of respondents expected their budgets for both new and used laboratory equipment to grow in 2024. Such constrained funding limits the ability of labs to upgrade their technology and broaden their assay capacities.

Adding to these financial hurdles is the intense need for highly trained experts who can run these complex machines and decipher intricate analytical data. A shortage of skilled personnel proficient in high-level protein assays and bioinformatics drives up daily operating expenses, driven by the need for lengthy training programs and premium salaries. Ultimately, the combined weight of massive upfront costs and the struggle to secure specialized talent curtails broader market growth by raising the overall expense and restricting access to these indispensable scientific resources.

Market Trends

The creation of multiplexed and high-throughput assay systems is a defining trend transforming the Global Protein Assays Market, allowing researchers to evaluate multiple protein targets across numerous samples simultaneously. This leap in technology vastly improves the speed of protein characterization, which is essential for massive proteomics initiatives and pharmaceutical discovery.

Processing larger datasets while using fewer reagents and smaller sample volumes helps decrease individual sample costs and speeds up research cycles. For instance, Proteomics Industry News reported in February 2025 that the UK Biobank Pharma Proteomics Project intends to measure over 5,400 proteins in 600,000 samples utilizing systems like Thermo Fisher Scientific’s Orbitrap Ascend Ultra. This emphasis on multiplexing perfectly aligns with the surging need for fast, thorough protein profiling in both clinical and research settings.

Another revolutionary trend is the incorporation of machine learning and artificial intelligence into assay evaluation, which elevates traditional data handling into advanced predictive modeling. By recognizing intricate patterns within the massive datasets produced by protein assays, AI and ML technologies enhance precision, clear analytical logjams, and uncover unseen drug targets and biomarkers.

This shift allows for more accurate quantification, automated quality checks, and enriched insights into cellular networks. Highlighting this trend, Benzinga reported in April 2026 that the PRECISE-SG100K study is leveraging Seer Inc.’s Proteograph Product Suite alongside other technologies to map the plasma proteomes of 10,000 individuals, ultimately accelerating biomarker detection. These smart analytical instruments are critical for maximizing the utility of complex assay data, driving progress in biopharmaceuticals and targeted therapies.

Key Market Players

• Becton Dickinson and Co
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories Inc
• Merck KGaA
• Abcam PLC
• PerkinElmer Inc.
• QIAGEN NV
• Lonza Group AG
• Bio-Techne Corp
• Illumina Inc

Report Scope

In this report, the Global Protein Assays Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Protein Assays Market, By Type:

• Dye Binding Assays
• Test Strip-Based Assays
• Copper-Ion-Based Assays
• Others

Protein Assays Market, By Product:

• Reagents
• Kits
• Instruments
• Accessories

Protein Assays Market, By Technology:

• Colorimetric Protein Assays
• Fluorescence-Based Protein Assays
• Absorbance-Based Protein Assays

Protein Assays Market, By Application:

• Drug Discovery and Development
• Disease Diagnosis
• Others

Protein Assays Market, By End User:

• Pharmaceutical and Biotechnology Companies
• Clinical Laboratories
• Hospitals
• Academic Research Institutes
• Others

Protein Assays Market, By Region:

• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Protein Assays Market .

Available Customizations

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.